Drug Pipeline

Perampanel Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05786066 The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects Depressive Disorder Recruiting
Phase 1
NCT05915013 Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the… Depressive Disorder, Major Recruiting
Early Phase 1
NCT07284069 Senicapoc and Perampanel for Newly Diagnosed Glioblastoma Glioblastoma Recruiting
Sponsors Running Perampanel Trials
Yale University (2) Aarhus University Hospital (1)
Disease Areas
Depression (2) Bipolar Disorder (1) Glioblastoma (1)
Get alerts when Perampanel trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free